Recent Quotes

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what we believe to be a key underlying cause of Alzheimer's disease. The company's lead drug candidate, ACU193, is a subclass monoclonal antibody which selectively targets amyloid-beta oligomers.

Analyst Ratings

Date	Analyst Firm	Analyst Name	Action	Rating	Action Price	Prior Price	Target

Related Companies

Ticker	Company	Price	Change	Chg %		Mkt Cap
ABOS	Acumen Pharmaceuticals	14.90	0.40	2.76%		575.9M

Acumen Pharmaceuticals Frequently Asked Questions

How do I buy Acumen Pharmaceuticals (ABOS) stock?

You can purchase shares of Acumen Pharmaceuticals (NASDAQ: ABOS) through any online brokerage.

View our list of the best stock brokerages.

Who are Acumen Pharmaceuticals's (ABOS) competitors?

There are no as such competitors for Acumen Pharmaceuticals.

What is the target price for Acumen Pharmaceuticals (ABOS) stock?

The latest price target for Acumen Pharmaceuticals (NASDAQ: ABOS) was reported by UBS on July 26, 2021. The analyst firm set a price target for 27.00 expecting ABOS to rise to within 12 months (a possible 81.21% upside). 4 analyst firms have reported ratings in the last year.

Current Stock Price for Acumen Pharmaceuticals (ABOS)?

The stock price for Acumen Pharmaceuticals (NASDAQ: ABOS) is $14.9 last updated Wed Jul 28 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Does Acumen Pharmaceuticals (ABOS) pay a dividend?

There are no upcoming dividends for Acumen Pharmaceuticals.

When is Acumen Pharmaceuticals (NASDAQ:ABOS) reporting earnings?

Acumen Pharmaceuticals does not have any upcoming earnings scheduled.

Is Acumen Pharmaceuticals (ABOS) going to split?

There is no upcoming split for Acumen Pharmaceuticals.

What sector and industry does Acumen Pharmaceuticals (ABOS) operate in?

Acumen Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.